Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT03833323
What this trial is testing

Implantable System for Remodulin Post-Approval Study

Who this might be right for
Pulmonary Arterial Hypertension
Medtronic Cardiac Rhythm and Heart Failure
Testing effectiveness (Phase 2)Study completedNCT04266197
What this trial is testing

Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study

Who this might be right for
Pulmonary Arterial Hypertension
Respira Therapeutics, Inc. 42
Large-scale testing (Phase 3)Study completedNCT00091598
What this trial is testing

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Hypertension
Gilead Sciences 372
Not applicableUnknownNCT04570228
What this trial is testing

TROPHY PAH Pivotal Study - TReatment of Pulmonary HYpertension for PAH Pivotal Study

Who this might be right for
Pulmonary Arterial Hypertension
SoniVie Inc. 205
Testing effectiveness (Phase 2)Study completedNCT01545336
What this trial is testing

Anastrozole in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
University of Pennsylvania 18
Post-approval studies (Phase 4)Study completedNCT00741819
What this trial is testing

Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 73
Testing effectiveness (Phase 2)Ended earlyNCT02651272
What this trial is testing

Macitentan in Pulmonary Hypertension of Sickle Cell Disease

Who this might be right for
Pulmonary HypertensionSickle Cell Disease
Boston University 4
Post-approval studies (Phase 4)Ended earlyNCT01433328
What this trial is testing

Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain

Who this might be right for
Pulmonary Arterial Hypertension
Jewish General Hospital 4
Not applicableStudy completedNCT01484899
What this trial is testing

Smoking: a Risk Factor for Pulmonary Arterial Hypertension?

Who this might be right for
Pulmonary Hypertension
University of Zurich 500
Not applicableLooking for participantsNCT05464095
What this trial is testing

The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study

Who this might be right for
Pulmonary Arterial Hypertension
Vanderbilt University Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT01484431
What this trial is testing

A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Eli Lilly and Company 20
Testing effectiveness (Phase 2)Ended earlyNCT03884465
What this trial is testing

Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil

Who this might be right for
Pulmonary Arterial Hypertension
Liquidia Technologies, Inc. 15
Large-scale testing (Phase 3)Study completedNCT00626028
What this trial is testing

Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing

Who this might be right for
Idiopathic Pulmonary Arterial HypertensionCardiomyopathy
Mallinckrodt 136
Not applicableStudy completedNCT02565030
What this trial is testing

Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term Outcome

Who this might be right for
Chronic Thromboembolic Pulmonary HypertensionIdiopathic Pulmonary Arterial Hypertension
Sheffield Teaching Hospitals NHS Foundation Trust 1,200
Not applicableStudy completedNCT00621075
What this trial is testing

Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans

Who this might be right for
Pulmonary Arterial Hypertension
Northwell Health 50
Testing effectiveness (Phase 2)Study completedNCT02036970
What this trial is testing

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

Who this might be right for
Pulmonary Arterial HypertensionPulmonary HypertensionInterstitial Lung Disease+9 more
Biogen 166
Not applicableStudy completedNCT02318186
What this trial is testing

Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Jeffrey A. Feinstein 51
Large-scale testing (Phase 3)Looking for participantsNCT07245680
What this trial is testing

COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities

Who this might be right for
Pulmonary Arterial Hypertension (PAH)ComorbiditiesCardiovascular Disease (CVD)
Assistance Publique - Hôpitaux de Paris 186
Post-approval studies (Phase 4)UnknownNCT00705588
What this trial is testing

Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.

Who this might be right for
Pulmonary Arterial Hypertension
Rabin Medical Center 30
Not applicableWithdrawnNCT02339961
What this trial is testing

Evaluating Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis

Who this might be right for
Systemic SclerosisPulmonary Hypertension
Echosense Ltd.
Next Page